Evidence map›Paper›PMID 12161590›Full record

ReviewJournal of medical genetics2002

Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

R S Wildin, S Smyk-Pearson, A H Filipovich

2 registry-linked trialsOpen access · bronzeAbstract readCase ReportsReview
In one paragraph

Review in Journal of medical genetics, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 250 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
250citing papers in PubMed, 3 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01050855 phase2completednot on this mapstarted 2008, after this paper: background citation

Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders

TypeinterventionalSponsorChildren's Hospital of PhiladelphiaRan2008 to 2025Enrolled56ConditionsNon Malignant Diseases, Immunodeficiencies, HemoglobinopathiesArmsReduced-Intensity Conditioning
NCT03835312 narecruitingnot on this mapstarted 2019, after this paper: background citation

Sequential Transplantation of Umbilical Cord Blood Stem Cells and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency Type 1 Diabetes Mellitus

TypeinterventionalSponsorChildren's Hospital of Fudan UniversityRan2019 to 2030Enrolled50ConditionsDiabetes Mellitus, Type 1, Immunologic Deficiency SyndromesArmsSequential transplantation
3 · Its place in the literature

Who cites it

250 citing papers in PubMed, 3 syntheses or guidelines pooled it, 702 citations in OpenAlex.

  1. Pooled it
  2. Meta-analysis reveals significant association betweenThe Journal of international medical research · 2021
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

190 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

R S WildinDepartment of Molecular and Medical Genetics, Oregon Health Sciences University, Mailcode MP350, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098, USA. wild@alum.mit.edu
S Smyk-Pearson
A H Filipovich
Cincinnati Children's Hospital Medical Center · USOregon Health & Science University · USUniversity of Portland · US

Funding

FOXP3 Gene Therapy for Immunomodulation in DiabetesR21DK060207 · NIDDK · OREGON HEALTH AND SCIENCE UNIVERSITY · PI WILDIN, ROBERT S · 2001 to 2001
$150k
MOLECULAR DISSECTION OF CONGENITAL NEPHROGENIC DIR29DK047278 · NIDDK · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WILDIN, ROBERT S · 1996 to 2000
$85k
NIDDK NIH HHS R21-DK60207NIDDK NIH HHS R29 DK47278
6 · The paper itself

Abstract

Immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX, OMIM 304790) is a rare, recessive disorder resulting in aggressive autoimmunity and early death. Mutations in FOXP3 have been identified in 13 of 14 patients tested. Research in the mouse model, scurfy, suggests that autoimmunity may stem from a lack of working regulatory T cells. We review published reports regarding the genetics, clinical features, immunology, pathology, and treatment of IPEX. We also report three new patients who were treated with long term immunosuppression, followed by bone marrow transplantation in two. IPEX can be differentiated from other genetic immune disorders by its genetics, clinical presentation, characteristic pattern of pathology, and, except for high IgE, absence of substantial laboratory evidence of immunodeficiency. While chronic treatment with immunosuppressive drugs may provide temporary benefit for some patients, it does not cause complete remission. Remission has been observed with bone marrow transplantation despite incomplete engraftment, but the long term outcome is uncertain.

Indexed as

AdolescentAnimalsAutoimmune DiseasesChildChild, PreschoolDiabetes Mellitus, Type 1Diagnosis, DifferentialDisease Models, AnimalHumansLymphoproliferative DisordersMalePolyendocrinopathies, AutoimmuneProtein-Losing EnteropathiesSyndrome

Identifiers

PMID12161590
PMCPMC1735203
OpenAlexW2166725781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.